Previous Article | Next Article ![]()
Eukaryotic Cell, June 2003, p. 474-485, Vol. 2, No. 3
1535-9778/03/$08.00+0 DOI: 10.1128/EC.2.3.474-485.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
David J. Seastone,2 Ed Harris,2 James A. Cardelli,2 and David A. Knecht1*
Department of Molecular and Cell Biology, University of Connecticut, Storrs, Connecticut 06269,1 Department of Microbiology and Immunology, Louisiana State University Medical Center, Shreveport, Louisiana 711302
Received 4 November 2002/ Accepted 1 March 2003
|
|
|---|
|
|
|---|
Dictyostelium is a useful model system to study actin dynamics and cell motility and is a professional chemotactic phagocyte comparable to macrophages or neutrophils. Restriction enzyme-mediated integration screening identified RacE, a member of the Rho family, as an important regulator of cytokinesis (12). Thirteen other Rho family genes have been identified in Dictyostelium (4, 26); however, their specific functions are not yet understood. In a previous report, we showed that RacC overexpression leads to the formation of an unusual actin-containing protrusion at the cell surface and a threefold increase in phagocytosis while macropinocytosis rates were significantly reduced (29). RacF1 was shown to localize at macropinocytic cups, phagocytic cups, and cell-cell adhesions (26); however, the function of this protein is less clear. Recently, the function of Rac1 proteins was investigated by several groups. Overexpression of the constitutively active form of Rac1 generated lamellopodia, inhibited macropinocytosis (8, 19), and resulted in defects in growth and cytokinesis. Overexpression of the dominant negative form of Rac1 protein induced only modest effects on cell morphology and, in one study, inhibited chemotactic movement of cells (5). Together, these data indicate that Dictyostelium Rac1 proteins play a role in regulation of actin cytoskeleton and actin related activities comparable to that observed for mammalian cells.
In this study we have generated cell lines that conditionally express wild-type and mutant forms of RacB to identify the role of RacB in actin cytoskeletal function and determine whether it shares functional redundancy with other Dictyostelium Rac proteins. Dictyostelium RacB has 50, 70, and 60% amino acid homology to Dictyostelium RacC, human Rac1, and human Cdc42, respectively. Our results suggest that RacB regulates polymerization of F-actin but in a manner that is different from the mechanism used by other Rac genes so far investigated. The spherical protrusions induced by the constitutively active form of RacB (V12-RacB) are dependent on actin polymerization but not on myosin II and are different from the petalopods produced by RacC overexpression. Expression of V12-RacB arrested cell growth, suggesting that RacB might also affect the cell cycle and/or cytokinesis. In addition, expression of V12-RacB dramatically reduced endocytosis, phagocytosis, and endosomal efflux while expression of WT-RacB and N17-RacB had lesser effects. We propose that RacB is normally involved in the control of cortical actin polymerization. The unique morphology of the V12-RacB-induced structures indicates that the pathway acting downstream of RacB is used to generate a unique form of cell protrusions distinguishable from those induced by RacC or Rac1 expression.
|
|
|---|
ATG, thus placing RacB in-frame with a 10-amino-acid-encoding epitope tag from the hemagglutinin (HA) protein of influenza virus to make the vector, WT-RacB. This vector contained the discoidin I promoter, which can be induced with prestarvation factor (23) and repressed by growing cells in the presence of folate (3). Site-directed mutagenesis was performed to replace glycine 12 by valine in the RacB sequence to generate a constitutively active form of RacB named V12-RacB. Dominant negative RacB was generated by mutating Thr-17 to Asn and was named N17-RacB. These three constructs were transformed into Ax4 wild-type cells by electroporation (21). Transformants were selected with 20 µg of G418 (Sigma Chemical Co.) per ml in HL5 medium containing 1 mM folic acid (Research Organics) to repress RacB gene expression from the plasmid. G418-resistant cells were cloned on a lawn of Klebsiella aerogenes, and six colonies were picked to 24-well plates and maintained in folic acid and G418. Replicas of each clone were grown for 3 days in the presence of 20 µg of G418 per ml but in the absence of folic acid to induce expression of RacB. Levels of exogenously expressed RacB proteins were determined by Western blot analysis using an anti-HA antibody (Clonetech, Inc.) and rabbit anti-RacB antibody. Antibodies to RacB were generated by expressing RacB as a glutathione S-transferase fusion protein in Escherichia coli. Purified GST-RacB was injected into rabbits, and serum was collected. Three clones that expressed RacB proteins no more than twofold over endogenous levels were retained and maintained in the presence of 1 mM folic acid and 20 µg of G418 per ml at low density (less than 105 cells/ml). To induce protein expression from the discoidin promoter, cells were plated at low density on fresh HL5 medium lacking folic acid and G418 and grown for 24 to 36 h. To visualize F-actin dynamics in cells expressing mutant RacB genes, pVE-HA-RacB, pVE-HA-N17RacB, and pVE-HA-V12RacB plasmids were transformed using G418 selection into Ax4 cells expressing the green fluorescent protein (GFP)-actin binding domain (ABD) fusion protein from a hygromycin-selectable plasmid (21). Resistant cells were cloned and maintained in the presence of 1 mM folic acid, 20 µg of G418 per ml and 25 µg of hygromycin (Calbiochem, Inc.) per ml at low density.
Cells lacking myosin II heavy chain (mhcA) were derived from HS1, in which the MhcA coding sequence was deleted (28). These cells were transformed with the pVE-HA-V12RacB vector and selected for G418 resistance under repressed conditions. The cells were then induced for V12-RacB expression as described above and in the figure legends.
Measurement of growth rate. Parental Ax4 and mutant cells were added to a 96-well plate in 100 µl of HL5 at 5 x 103 cells/ml. Every 10 to 14 h, cells were removed from a well and the cell density was measured using a hemocytometer. Two wells were used for each measurement, and the results were averaged.
Fluorescence microscopy. For phalloidin staining of F-actin, cells grown on a coverslip were fixed for 20 min with HL5 medium containing 1% formaldehyde, 0.1% glutaraldehyde (EM grade from Polysciences Inc.), 0.01% Triton X-100, and 1 µM TRITC-phalloidin (Sigma Co.). The fixation solution was made fresh at 2x concentration and mixed with an equal volume of cells in HL5. For nuclear staining, cells were fixed with 100% cold methanol for 15 min, washed with MCPB (10 mM Na2HPO4, 10 mM KH2PO4, 2 mM MgCl2, 0.2 mM CaCl2 [pH 6.5]), and then treated with 100 µg of RNase A per ml in TE (20 mM Tris, 1 mM EDTA [pH 7.5]). After a 1-h incubation, 10 µM propidium iodide was added and the mixture was incubated for an additional 30 min. The coverslip was washed with MCPB before being imaged.
Fluorescence images were collected using a Bio-Rad MRC-600 confocal laser-scanning microscope equipped with a 25-mW krypton-argon laser (Ion Laser Technology) attenuated with a 1% neutral-density filter. A 100x (1.30 NA) Neofluar oil immersion objective (Carl Zeiss Inc.) was used. Differential interference contrast (DIC) or phase contrast images and fluorescence images were collected simultaneously using the lowest direct scan rate and analyzed using NIH-Image (written by Wayne Rasband at the U.S. National Institutes of Health and available from the Internet by anonymous FTP from zippy.nimh.nih.gov.). Some images were further enhanced using Adobe Photoshop.
SEM. Scanning electron microscopy (SEM) was performed using the method of Fleurat-Lessard and Satter with minor modifications (8a). Cells were fixed for 30 min with HL5 containing 1% formaldehyde, 0.1% glutaraldehyde, and 0.01% Triton X-100. Further fixation was carried out using 2% glutaraldehyde in 50 mM HEPES buffer (pH 7.0) for 1 h and 1% OsO4 in 50 mM HEPES buffer (pH 7.0) for 4 h. After dehydration with ethanol, the cells were critical-point dried and coated with gold. A LEO982 (Carl Zeiss Inc.) field emission scanning electron microscope was used at an accelerating voltage of 2.0 kV.
Drug treatment. Butadione monoxime (BDM; Sigma) was made fresh in HL5 and used at 20 mM final concentration. Cells were grown on a coverslip for 2 days, and the drug was added for 30 min prior to imaging. Fields of cells were imaged using an inverted microsope (Carl Zeiss, Inc.) equipped with a 40x DIC objective and a charge-coupled device camera.
Induction of blebbing in wild-type and mhcA cells. Anoxia and electroporation were used in order to induce blebbing of cells. Cells were plated onto coverslips lying in the bottom of a petri dish. After overnight growth, a coverslip was removed and placed in a Rose chamber with the cells facing up. A circular Teflon spacer was placed on the top of the glass coverslip containing cells, HL5 medium was added, and then another coverslip was placed on the top of the Teflon spacer. The top part of the Rose chamber was placed on the top glass coverslip, and the assembly was screwed together to seal the chamber. Blebbing was reproducibly observed within 10 min after the chamber was sealed. In some experiments, cells were preincubated with 20 mM BDM for 10 min. The coverslip containing cells was then mounted in the Rose chamber as above with medium containing BDM.
Electroporation also induces blebbing of cells. The protocol used was the same as for transformation of cells with DNA (21). Briefly, cells were placed in a cold 0.1-cm cuvette in H-50 buffer (20 mM HEPES, 50 mM KCl, 10 mM NaCl, 1 mM Mg2SO4, 5 mM NaHCO3, 1 mM Na2HPO4 [pH 7.0]) and pulsed at 0.85 kV and then 0.15 kV with a capacitance of 25 µF. The cells were removed from the cuvette and mixed with 500 µl of HL5 medium in an open Rose chamber immediately after electroporation, and imaging was started after 5 min.
Measurement of the number of pseudopods. Parental cells and V12-RacB cells were grown in a petri dish for 36 h to induce RacB expression and then detached from the substrate and shaken at 22°C for 10 min at 200 rpm. Cells were added to a petri dish, and images were captured in a focal plane above the dish surface, using 20x Hoffman modulation contrast microscopy, while the cells were settling to the bottom of the dish. The number of pseudopods on each cell was then determined.
Quantitation of F-actin. F-actin was quantified using a flow cytometer (Becton Dickson FACScaliber). Cells were grown in suspension culture starting at 2 x 105 cells/ml. After 24 to 36 h of growth, 1.5 ml of cells was collected and centifuged at 800 x g for 5 min in the cold. The cells were resuspended in 200 µl of MCPB and fixed by addition of 2x fixation solution containing 0.5 µM of TRITC-phalloidin. The buffer was gently aspirated after overnight incubation at 4°C and exchanged for fresh MCPB without disturbing the cells at the bottom. Finally, the cells were resuspended in 1 ml of MCPB and analyzed in the cytometer.
Total and cytoskeletal actin were also quantified by staining of protein bands on sodium dodecyl sulfate SDS-polyacrylamide gels. The harvested cells were lysed with L buffer (20 mM PIPES [pH 7.5], 50 mM KCl, 5 mM EGTA, 0.2 mM MgCl2, 5 mM dithiothreitol, 1 mM ATP) containing 0.5% Triton X-100 and 5 µg each of the protease inhibitors leupeptin, chymostatin, and pepstatin per ml. After quantification of protein by the Bradford assay (Bio-Rad, Inc.), the lysates were centrifuged at 8,000 x g for 4 min and the cytoskeletal pellet was resuspended in L buffer and centrifuged again (7). Equal amounts of total-cell extract and threefold larger amounts of cytoskeletal fractions were loaded onto a 10% polyacrylamide gel. The protein bands were stained using Coomassie blue, and the actin band was quantified by densitometry using NIH-Image.
Endocytosis, exocytosis, and phagocytosis measurements. For phagocytosis, fluid-phase pinocytosis, and exocytosis assays, exponentially growing cells were harvested from T-175 tissue culture flasks (Sarstedt Inc.) and resuspended in growth medium at a titer of 3 x 106 cells/ml. For phagocytosis assays, cells were exposed to 1-µm-diameter fluorescent crimson latex beads (Molecular Probes) in HL5 medium at a concentration of 50 beads/cell. Cells and beads were shaken at 150 rpm in 25-ml Erlenmeyer flasks for 90 min. At various times, 1-ml aliquots of cells were harvested by centrifugation (1,000 x g for 5 min) and washed twice with cold HL5 growth medium and once with sucrose buffer (5 mM glycine, 100 mM sucrose [pH 8.5]). The cells were lysed with 0.5% Triton X-100, and the intracellular fluorescence was measured by spectrofluorimetry using a 625-nm wavelength for excitation and a 645-nm wavelength for emission. The fluorescence of each of the samples was normalized to total-cell protein to account for any differences in cell sizes between the strains. For fluid-phase pinocytosis assays, fluorescein isothiocyarate-dextran (70,000 Mr; Sigma) was incubated with shaking cultures of cells in growth medium to a final concentration of 2 mg/ml for 2 h. At various times, the cells were harvested and lysed with 0.5% Triton X-100 and the intracellular fluorescence was calculated with a spectrofluorimeter using 492 nm for excitation and 525 nm for emission. For exocytosis assays, cells were loaded for 3 h with 70,000 Mr FITC-dextran. The cells were washed twice with cold HL5 medium and resuspended in growth medium. At various times, they were harvested and lysed with 0.5% Triton X-100 and the intracellular fluorescence was determined as described above. To determine the percent fluorescence remaining in the cells, the fluorescence value at each time point was compared with the fluorescence at time zero, which was given a value of 100%.
|
|
|---|
![]() View larger version (73K): [in a new window] |
FIG. 1. Cell morphology changes induced by expression of RacB. (A to E) Cells were grown for 36 h in the presence or absence of folic acid, and phase-contrast images were captured. Wild-type Ax4 cells in the absence of folic acid (A), V12-RacB cells in fresh medium containing 1 mM folic acid (B), and WT-RacB cells (C), V12-RacB cells (D), and WT-RacC cells (E) in the absence of folic acid are shown. The morphology of WT-RacB, V12-RacB, and WT-RacC cells in the presence of folic acid is almost identical to that of parental cells but is dramatically changed on induction. WT-RacB cells became flattened, V12-RacB cells became detached with numerous protrusions on the cell surface, and WT-RacC cells became relatively flat with irregular contours on the surface. Bar, 20 µm. (F) Expression of WT-RacB and V12-RacB. Extracts of 2 x 105 parental, V12-RacB, and WT-RacB cells were harvested and run on an SDS-10% polyacrylamide gel. Expression of RacB was detected by rabbit polyclonal antibody against RacB (right panel) or by anti-HA antibody (left panel). In the presence of folate at low cell density (2 x 105 cells/ml), the recombinant protein was barely detectable (- lanes); however, it was induced twofold over the endogenous RacB level at high cell density in the absence of folic acid (+ lanes).
|
To determine if cells expressing different forms of RacB proteins could grow and divide normally, wild-type AX4 and mutant cells were grown in a 96-well plate in the absence of folic acid and the titer was recorded over time. Surprisingly, cells expressing V12-RacB stopped dividing, so that the cell density did not increase for at least 36 h after folic acid removal (Fig. 2). Some cells lysed during the 3 days of growth under the induced conditions; however, the majority of the cells were viable since more than 80% of the cells could grow to form colonies on a bacterial lawn (our unpublished results). In contrast, the growth rate was not significantly inhibited in cells overexpressing WT-RacB (Fig. 2) or N17-RacB (our unpublished results). Since a more dramatic effect was observed in cells expressing V12-RacB, further studies were focused on functional characterization of V12-RacB cells.
![]() View larger version (18K): [in a new window] |
FIG. 2. Growth of parental, WT-RacB, and V12-RacB cells. Equal numbers of cells from each cell line were added to wells of a microtiter plate. Cells from two wells were taken every 10 to 14 h to determine the average cell density. Parental Ax4 cells have an 11-h generation time, while V12-RacB cells stopped growing 36 h after folic acid removal. WT-RacB cells had a slightly lower growth rate.
|
![]() View larger version (44K): [in a new window] |
FIG. 3. Nuclear staining of parental and V12-RacB cells. (A) Cells were grown for 3 days under induced conditions and stained with 1 µM propidium iodide to visualize nuclei. Left panels are DIC images, and right panels show the nuclear staining. The upper panels are wild-type cells, and the lower panels V12-RacB cells. The arrowhead indicates heterogeneous sizes of nuclei in V12-RacB cells. (B) The number of nuclei was counted from 157 parental and 97 V12-RacB-expressing cells. In parental cells, 87% contain one or two nuclei, as opposed to 26% in V12-RacB population. The number of nuclei in cells expressing V12-RacB ranged from 1 to 15, compared to 1 to 5 in wild-type cells.
|
![]() View larger version (64K): [in a new window] |
FIG. 4. Scanning electron micrographs of parental and V12-RacB cells. Cells were grown on glass coverslips and prepared for SEM after 2 days of growth in the absence of folic acid. (A) Parental cells have a thick center with protrusions at the cell edge. (B) V12-RacB cells have numerous irregular protrusions on the cell surface. (C) Some V12-RacB cells remain flattened on the surface and contain numerous protrusions at the cell edges. Bar, 5 µm.
|
![]() View larger version (89K): [in a new window] |
FIG. 5. Comparison of V12-RacB protrusions to stress-induced blebs. (A and E) Cells were sealed between two coverslips in a Rose chamber and imaged at 1-min intervals. The cells stopped moving after 5 to 10 min in the sealed chamber and began to form blebs. Control cells before sealing (A) and after 20 min in the chamber (E) are shown. (B and F) V12-RacB (Ax4 parental) cells contained surface protrusions (B), but after treatment with 10 µM cytochalasin A for 5 min, the protrusions were lost from the surface (F). (C and G) Myosin null cells (mhcA) before sealing (C) and after a 20-min (G) or 1-h incubation. The cells did not show any blebbing after incubation (our unpublished results). (D and H) Expression of V12-RacB was induced for 3 days in JH10, a parental cell line of mhcA cells (D), and in mhcA cells (H). Surface protrusions were induced in both cell lines. Bar, 5 µm.
|
Changes in the actin cytoskeleton. Since the V12-RacB cells have increased numbers of protrusions, it is possible that the amount of F-actin in these cells might be elevated. To test this hypothesis, cells were fixed and stained with TRITC-phalloidin and the level of fluorescence was examined using flow cytometry. From forward-scatter data, it was apparent that cell size was generally increased in V12-RacB cells (Fig. 6A). This is presumed to be due to a defect of cytokinesis and karyokinesis in V12-RacB cells (Fig. 2 and 3); however, it is possible that it reflects the altered shape of the cells. When cells of the same forward-scatter range (R3 or R5) were examined for their fluorescence intensity, V12-RacB cells showed a 77% (R3) and 56% (R5) increase in mean fluorescence (Fig. 6C and D; Table 1). This indicates that V12-RacB expression leads to an increase in the amount of F-actin in cells. In addition, the amount of F-actin associated with the Triton-insoluble cytoskeleton was increased twofold relative to parental cells (from 30% to nearly 59%) in V12-RacB cells (Fig. 6E; Table 1). The increase in the amount of F-actin was not accompanied by an increase in the amount of total actin, thus, the ratio of F- to G-actin was increased in V12-RacB cells. These results confirm that V12-RacB induces actin polymerization in these cells.
![]() ![]() View larger version (118K): [in a new window] |
FIG. 6. V12-RacB increases the amount of F-actin in cells. (A and B) The forward scatter (FSC) data from flow cytometry of parental (A) and V12-RacB (B) cells shows that the average size was increased about twofold in V12-RacB-expressing cells. F-actin was quantified by measuring the TRITC-phalloidin fluorescence of cells of similar size. Two areas, marked R3 and R5, indicate two different size ranges of cells. (C and D) The fluorescence intensity of cells in each size range was plotted (R3 and R5, respectively). The solid gray line represents the fluorescence intensity of the parental Ax4 cells, and the black line represents the V12RacB cells. (E) The amount of actin was also quantified by SDS-polyacrylamide gel electrophoresis by loading whole-cell extracts and cytoskeletal fractions on a gel. The total amount of actin was not changed significantly; however, the amount of cytoskeleton-associated F-actin increased about twofold in V12-RacB-expressing cells (see Table 1).
|
|
View this table: [in a new window] |
TABLE 1. F-actin quantitation in cells
|
![]() View larger version (147K): [in a new window] |
FIG. 7. Three-dimensional localization of F-actin. Cells were fixed and stained with TRITC-phalloidin, and confocal z sections were acquired. (A) Wild-type cells. Images are shown at 1.4-µm z intervals. (B) V12-RacB cells. Images are shown at 3-µm z intervals. Note that the protrusions on the cell surface are enriched in F-actin. (C) WT-RacC cells. Images are shown at 1.5-µm z intervals. Note that these deformations of the cortex are not actin filled. Bar, 5 µm.
|
![]() View larger version (112K): [in a new window] |
FIG.8. Visualization of actin dynamics in live cells, using GFP-ABD. (A) Parental Ax4 cells expressing GFP-ABD were observed by confocal microscopy at 20-s intervals. GFP-ABD localizes to the actin cortex and new protrusions as they form at the periphery of the cell (arrow). (B) Cells coexpressing GFP-ABD and V12-RacB were induced for 2 days, and time-lapse images were acquired at 20-s intervals. Cells became detached and actively formed actin-containing spherical protrusions (arrow). (C) Ax4 cells expressing GFP-ABD were electroporated, and the process of bleb formation was visualized by confocal microscopy at 7-s intervals. Note the lack of staining of the bleb. (D) Cells coexpressing GFP-ABD and WT-RacC were induced for 2 days, and time-lapse images were acquired at 20-s intervals. Cells deform the actin cortex both inwardly (arrowhead) and outwardly (arrow). Bar, 5 µm.
|
![]() View larger version (20K): [in a new window] |
FIG. 9. Quantitation of phagocytosis, macropinocytosis, and recycling rates. (A) Uptake of fluorescent beads by phagocytosis. (B) Uptake of fluorescent dextran by endocytosis. (C) Efflux of the endocytic probe. Efflux was measured by feeding cells with fluorescent dextran for 3 h and then measuring the fluorescence remaining at each time point.
|
|
|
|---|
Cells overexpressing N17-RacB appeared morphologically normal, while cells overexpressing WT-RacB became flattened. Furthermore, most of the cells expressing V12-RacB became detached from the substrate and formed many surface protrusions, while a small proportion remained attached, became flattened, and showed a similar morphology to WT-RacB overexpressing cells. Cells stopped growing following expression of V12-RacB. V12-RacB expression does not simply inhibit cytokinesis, because the increase in the size of cells and the accumulation of nuclei in cells over time were much smaller than those observed with a myosin II mutation in which cytokinesis is totally blocked. It is more likely that expression of RacB affects cell growth and the cell cycle, as has been suggested for other systems (18, 30).
The surface protrusions produced by V12-RacB cells resemble apoptotic membrane blebs; however, characteristics of apoptosis such as nuclear condensation, chromosome degradation, and phosphatidylserine exposure were not observed in cells overexpressing V12-RacB (E. Lee, unpublished observations). A role for myosin II in apoptotic blebbing has been suggested from studies using the inhibitors of myosin light-chain kinase (13). Consistent with this, BDM, a myosin ATPase inhibitor, stalled the retraction and expansion of apoptotic blebbing (13). BDM treatment eliminated the spherical protrusions in V12-RacB cells, suggesting that the protrusions formed by V12-RacB might be dependent on a myosin ATPase (our unpublished results). However, when V12-RacB was expressed in a myosin II heavy-chain null mutant, protrusions were still formed. Therefore, it is possible that a myosin other than myosin II might play a role in the formation of the protrusions induced by V12-RacB. In contrast, blebs formed by wild-type cells under stress were myosin II dependent. Thus, we conclude that the spherical protrusions observed in V12-RacB-expressing cells are a form of protrusion different from the passive blebs found after stress or apoptosis, which are myosin II dependent. Rather, RacB-induced protrusions depend on actin polymerization since cytochalasin A treatment inhibits their formation. Consistent with this, we have observed that the levels of F-actin increase twofold in cells overexpressing V12-RacB.
Both V12-RacB-expressing cells and WT-RacC-expressing cells display surface protrusions; however, there are clear differences in the nature of these structures. V12-RacB expression results in cells detaching from the substratum and induces a threefold increase in the number of protrusions. The protrusions are fairly small and regular and appear to form on top of the existing cortex, so that even with these protrusions, the cells remain overall spherical. Petalopodia are two to four times larger than the protrusions induced by V12-RacB and appear as if the entire cell margin is bulged outward. This difference is shown at the ultrastructural level by the difference in localization of F-actin in the two cell types. The V12-RacB protrusions appear to be actin filled, while the petalopods appear to stain only at the periphery. The fact that WT-RacC induces a significant increase in the phagocytosis rate of cells while V12-RacB causes a nearly complete shutdown in phagocytosis and WT-RacB slightly reduces phagocytosis also supports the idea that these two GTPases have dramatically different consequences for cortical organization and function. However, WT-RacC was expressed constitutively from an actin promoter while V12-RacB was expressed from the inducible discoidin promoter. It is still possible that the amount or mode of expression may affect the phenotypic consequences to the cell. Until more is known about the downstream signaling pathway, the conclusion that these two GTPases affect different actin polymerization pathways remains tentative.
Expression of RacB wild-type and mutant forms also had dramatic effects on trafficking into and along the endolysosomal pathway. Expression of V12-RacB resulted in greater than 75% reductions in the rate of phagocytosis, endocytosis of fluid, and exocytosis of fluid compared to wild-type cells. When phalloidin-stained cells were examined by confocal microscopy, there was no evidence of the crowns normally associated with macropinocytosis on the dorsal surface of V12-RacB cells. It seems likely that the surface protrusions are interfering with normal crown formation and thus with macropinocytosis. This suggests that the inability of the V12-RacB mutant to hydrolyze GTP, and thus to cycle between GTP- and GDP-bound states, leads to a strong mutant phenotype. In contrast, expression of constitutively active RacC (unpublished results) or Rac1B (19) did not significantly affect these processes.
We propose that RacB expression regulates outward protrusions by locally stimulating actin polymerization. In summary, consideration of the data described here for RacB suggests that all of the Dictyostelium Rac proteins described thus far, including RacF, RacC, RacE, Rac1, and RacB, play unique roles in regulating F-actin polymerization and generating specific types of actin-containing structures.
This work was supported by grants from the NIH to D. Knecht (GM 40599) and J. Cardelli (DK 39232).
Present address: Department of Cell Biology, Yale University School of Medicine, Boyer Center for Molecular Medicine, New Haven, CT 06510. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»